327 related articles for article (PubMed ID: 31938577)
1. Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma.
Zhu J; Wang M; Hu D
PeerJ; 2020; 8():e8288. PubMed ID: 31938577
[TBL] [Abstract][Full Text] [Related]
2. Prognosis-related autophagy genes in female lung adenocarcinoma.
Liu Z; Zhang K; Zhao Z; Qin Z; Tang H
Medicine (Baltimore); 2022 Jan; 101(1):e28500. PubMed ID: 35029906
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of Immune Implication and Prognostic Value of
Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
Front Oncol; 2021; 11():798425. PubMed ID: 35047409
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
5. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
[TBL] [Abstract][Full Text] [Related]
6. Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma.
Mao G; Yang D; Liu B; Zhang Y; Ma S; Dai S; Wang G; Tang W; Lu H; Cai S; Zhu J; Yang H
Respir Res; 2023 Jul; 24(1):176. PubMed ID: 37415224
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
8. Identification of Prognostic Immune-Related Genes by Integrating mRNA Expression and Methylation in Lung Adenocarcinoma.
Zhu J; Wang M; Hu D
Int J Genomics; 2020; 2020():9548632. PubMed ID: 32695805
[TBL] [Abstract][Full Text] [Related]
9. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Zengin T; Önal-Süzek T
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672117
[TBL] [Abstract][Full Text] [Related]
11. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Wang J; Zhan X
Front Immunol; 2021; 12():752643. PubMed ID: 34887858
[TBL] [Abstract][Full Text] [Related]
12. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Tian WJ; Liu SS; Li BR
Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
[TBL] [Abstract][Full Text] [Related]
13. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
14. A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma.
Wu G; Zhu Z; Yang Z; He M; Ren K; Dong Y; Xue Q
Int J Gen Med; 2022; 15():3991-4006. PubMed ID: 35437352
[TBL] [Abstract][Full Text] [Related]
15. Construction of a prognostic model for lung squamous cell carcinoma based on seven N6-methylandenosine-related autophagy genes.
Yu X; Liu J; Xie R; Chang M; Xu B; Zhu Y; Xie Y; Yang S
Math Biosci Eng; 2021 Aug; 18(5):6709-6723. PubMed ID: 34517553
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy.
Hu J; Xu L; Shou T; Chen Q
Transl Lung Cancer Res; 2019 Oct; 8(5):614-635. PubMed ID: 31737498
[TBL] [Abstract][Full Text] [Related]
17. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma.
Zhai WY; Duan FF; Chen S; Wang JY; Zhao ZR; Wang YZ; Rao BY; Lin YB; Long H
Front Cell Dev Biol; 2022; 10():770550. PubMed ID: 35300428
[TBL] [Abstract][Full Text] [Related]
18. Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.
Cao B; Wang P; Gu L; Liu J
Oncol Lett; 2021 Apr; 21(4):249. PubMed ID: 33664813
[TBL] [Abstract][Full Text] [Related]
19. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
20. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q
Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
